Visium Asset Management
View Older Stories
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form 8-K VISIUM TECHNOLOGIES, For: Aug 13
-
Form 8-K/A VISIUM TECHNOLOGIES, For: Jun 26
-
Form 8-K VISIUM TECHNOLOGIES, For: Jun 26
-
Form 10-Q VISIUM TECHNOLOGIES, For: Mar 31
-
Form 8-K VISIUM TECHNOLOGIES, For: May 06
-
Form 10-Q VISIUM TECHNOLOGIES, For: Dec 31
-
10x Genomics (TXG) Announces Preliminary Select Fourth Quarter and Full Year 2024 Results
-
Form 10-Q VISIUM TECHNOLOGIES, For: Sep 30
-
Canaccord Genuity Reiterates Buy Rating on 10X Genomics (TXG)
-
Form 8-K VISIUM TECHNOLOGIES, For: Sep 18
-
Form 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form 8-K VISIUM TECHNOLOGIES, For: Jul 25
-
Visium Technologies, Inc. Issues Letter to Shareholders
-
Form 10-Q VISIUM TECHNOLOGIES, For: Mar 31
-
Vizgen Announces Significant Win in Ongoing Patent Litigation Against 10x Genomics and Harvard University
-
Lit Thinking Launches Visium: A Revolutionary Light Which Continuously Eliminates Viruses and Pathogens from Indoor Air
-
10x Genomics Reports First Quarter 2024 Financial Results
-
10x Genomics (TXG) Commercially Launches Visium HD Spatial Gene Expression Assay
-
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
-
ATX Visium SBB Security Adapter Gains Traction in Commercial DIRECTV Installations
-
Form 10-Q VISIUM TECHNOLOGIES, For: Dec 31
-
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
-
Form NT 10-Q VISIUM TECHNOLOGIES, For: Dec 31
-
10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting
-
Ultima Genomics to Launch UG 100™ System and Present Data at AGBT
-
10x Genomics (TXG) Announces Preliminary Fourth Quarter and Full Year 2023 Results
-
10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
-
Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor Invasiveness
-
Form 8-K VISIUM TECHNOLOGIES, For: Dec 05
-
10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain
-
Form 8-K VISIUM TECHNOLOGIES, For: Nov 22
-
Visium Technologies Awarded Subcontract for $20 Million
-
Form 10-Q VISIUM TECHNOLOGIES, For: Sep 30
-
Form NT 10-Q VISIUM TECHNOLOGIES, For: Sep 30
-
Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.
-
Wasabi Technologies Partners with Leading Security Providers to Deliver Next-Generation Cloud Storage to Australia and New Zealand Surveillance Industry
-
OWKIN Integrates 10x Genomics (TXG) Spatial Omics and Single-Cell Technologies to the MOSAIC Study
-
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
-
10x Genomics Reports Third Quarter 2023 Financial Results
-
New API Extends the Utility of ATX Visium SBB Security Adapter in Enterprise Environments
-
Form 8-K VISIUM TECHNOLOGIES, For: Oct 19
-
Form 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
Form NT 10-K VISIUM TECHNOLOGIES, For: Jun 30
-
ATX to Showcase Broadband, Media Distribution and Energy Storage Expertise at SCTE Cable-Tec Expo 2023
-
Visium Technologies, Inc. Issues Letter to Shareholders
-
Visium Technologies Receives Letter of Intent from Cybastion Institute of Technology for Major Projects in Côte d'Ivoire
-
Form 8-K VISIUM TECHNOLOGIES, For: Sep 12
-
Visium Technologies Retires Variable Rate Convertible Note
-
Visium Technologies Retires Variable Rate Convertible Note

